Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
A Study Evaluating the Safety and Efficacy of Transplantation of a single cord blood unit
(CBU) of NiCord®, umbilical cord blood-derived Ex Vivo Expanded Stem and Progenitor Cells in
Patients with Hematological Malignancies.